Public health on both sides of the border.
A scientific team from the National Autonomous University of Mexico (UNAM) is developing an innovative treatment in the form of eye drops that could transform the management of diabetic retinopathy.
In the global race to understand Alzheimer’s, Mexican research has marked a turning point by more precisely locating the origin of brain damage and opening new possibilities to detect it in early stages through non-invasive methods.
Guillermo Herrera-Arcos, co-author of a study published in the scientific journal Nature, which presents a breakthrough in the development of myoneural actuators (MNA), biological devices designed to integrate into the body and restore function in weakened or paralyzed organs.
The “Ignacio Chávez” National Institute of Cardiology (INCICH), has been officially certified as a Comprehensive Heart Failure Center by the American Heart Association (AHA).
Eduardo Clark García Dobarganes, Deputy Minister for Sectoral Integration and Coordination of Medical Care, confirmed that after five weeks of negotiations
Since the creation of the IMSS Stem Cell Bank in 2005, it has treated hemato-oncological diseases, earning international certification.
As the world marks World Mental Health Day on October 10, international organizations and Mexican authorities are warning about the growing emotional vulnerability of youth mental health.
Mexico’s Instituto Politécnico Nacional —National Polytechnic Institute (IPN)— is advancing in the development of a rapid test to detect childhood leukemia.
Minister for Women Citlalli Hernández Mora announced that Mexico’s National Care System will be implemented progressively. Photo: Government of Mexico.
The Mexican Government announced a joint investment of over $642.7 Million USD (12 billion pesos) by four pharmaceutical companies.
Mexican company Grupo Bimbo has announced it will completely eliminate artificial colorants from all its products worldwide by the end of 2026.
Mexican President Claudia Sheinbaum Pardo announced on Tuesday that her administration will inaugurate 31 new hospitals and 12 healthcare centers between October 1, 2024, and December 31, 2025.
Mexico seeks reinvestment from pharmaceutical companies, from which it purchases 150 billion pesos (7.77 billion dollars) in single-source supplies every two years.
The director of the IMSS, Zoé Robledo, emphasized that MXN 25 billion would be invested in the construction of seven hospitals.
Mexico commits to prevention and early detection in the fight against tuberculosis
